Schweiter Technologies AG (SWX:SWTQ)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions CHF. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	501	591	743	1,054	1,936	2,090
Market Cap Growth	-5.39%	-20.42%	-29.48%	-45.56%	-7.40%	19.09%
Enterprise Value	506	610	782	1,060	1,873	2,028
Last Close Price	350.00	395.12	481.10	662.09	1170.68	1232.40
PE Ratio	85.11	44.46	26.92	36.21	22.94	20.20
Forward PE	13.53	13.81	15.31	20.76	19.22	24.98
PS Ratio	0.51	0.59	0.70	0.88	1.58	1.80
PB Ratio	0.74	0.82	1.05	1.40	2.49	2.83
P/TBV Ratio	1.03	1.12	1.43	1.82	3.27	3.79
P/FCF Ratio	9.53	9.11	15.95	-	47.68	17.23
P/OCF Ratio	7.26	6.90	9.49	21.86	23.38	13.25
PEG Ratio	-	63.22	63.22	63.22	63.22	2.34
EV/Sales Ratio	0.52	0.60	0.73	0.89	1.53	1.75
EV/EBITDA Ratio	7.38	10.45	10.23	15.21	13.70	12.44
EV/EBIT Ratio	25.93	28.13	16.10	25.42	17.29	15.08
EV/FCF Ratio	9.61	9.41	16.79	-	46.12	16.72
Debt / Equity Ratio	0.15	0.15	0.16	0.11	0.05	0.05
Debt / EBITDA Ratio	1.48	1.53	1.25	1.00	0.28	0.22
Debt / FCF Ratio	1.93	1.67	2.36	-	1.02	0.32
Asset Turnover	0.93	0.96	1.01	1.08	1.10	1.08
Inventory Turnover	2.80	2.74	2.86	3.16	3.33	3.33
Quick Ratio	1.19	1.26	1.29	1.36	1.73	2.04
Current Ratio	2.17	2.22	2.22	2.44	2.90	3.05
Return on Equity (ROE)	0.76%	1.81%	3.78%	3.81%	11.14%	14.12%
Return on Assets (ROA)	1.14%	1.28%	2.86%	2.34%	6.04%	7.82%
Return on Capital (ROIC)	1.49%	1.65%	3.68%	3.16%	8.49%	10.96%
Return on Capital Employed (ROCE)	2.40%	2.50%	5.80%	4.70%	11.40%	14.70%
Earnings Yield	1.18%	2.25%	3.71%	2.76%	4.36%	4.95%
FCF Yield	10.50%	10.97%	6.27%	-0.22%	2.10%	5.80%
Dividend Yield	4.16%	3.80%	3.12%	3.02%	3.42%	3.25%
Payout Ratio	364.41%	161.65%	103.62%	196.91%	67.89%	55.36%
Buyback Yield / Dilution	0.14%	0.00%	-	-	-	-
Total Shareholder Return	4.30%	3.80%	3.12%	3.02%	3.42%	3.25%

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.